David A. Dodd - 11 Aug 2021 Form 4 Insider Report for GeoVax Labs, Inc. (GOVX)

Reporting relationship: President, CEO, Director
Issuer ticker: GOVX
Reported as of: 11 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2021, 17:38:08 UTC
Next SEC filing: 08 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ David A. Dodd

Filing notes and source

Key filing fact

David A. Dodd filed Form 4 for GeoVax Labs, Inc. (GOVX) on 11 Aug 2021.

Key facts

This page summarizes David A. Dodd's Form 4 filing for GeoVax Labs, Inc. (GOVX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Aug 2021, 17:38.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GOVX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +273,000
Change %
Price: $0.000000
Shares after: 273,000
Date: 11 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 273,000
Exercise price: $2.79
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.

Footnote F2

Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.